Crypto.News
NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials.
Related articles
-
Solana (SOL) Risks Slipping Deeper Into The Red As Momentum Fades
NewsBTC Published 02.06.2026 04:28
-
XRP Price Prediction: Tomorrow’s XRP Ledger Update Could Send XRP Toward $10
Cryptonews Published 26.05.2026 18:49
-
Staking Now Drives 60% of Revenue at Ethereum Treasury Firms
BeInCrypto Published 26.05.2026 15:33
-
US Sanctions Iran’s Largest Crypto Exchange Nobitex in Major ‘Economic Fury’ Crackdown
CryptoPotato Published 03.06.2026 21:41
-
Live markets: Bitcoin slides further, putting two-month winning streak in jeopardy
CoinDesk Published 29.05.2026 14:50
-
DeFi’s automated yield protocols were built for retail, now they just add another layer of risk
CryptoSlate Published 28.05.2026 10:45
-
Bitcoin could be heading much lower, fund manager warns as $150 billion Treasury operation nears
CoinDesk Published 28.05.2026 04:55
-
Spain’s National Police Dismantle Violent Crypto-Robbery Ring Linked to Tren de Aragua
Bitcoin.com Published 30.05.2026 03:30